Cytokinetics Inc (CYTK)

EBITDA Growth

-80.98%

Quarterly · Period ending:

CYTK logo

CYTK EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-80.98%
CYTK Quarterly EBITDA YoY % (-2.84% → -80.98%)
High-resolution chart · PNG

CYTK ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytokinetics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-80.9785%
-24.3796%
-44.0864%
-104.0527%
7.5403%
-17.3626%
-10.173%
-19.6034%
-2.8197%
-0.6299%
4.9861%
8.7445%
-1,218.3192%
-46.2865%
-459.5775%
-81.6649%
84.0883%
-98.0545%
36.8245%
-1,297.6923%
-76.9208%
-32.817%
-53.6957%
125.3423%
-20.3529%
-29.7215%
-6.9361%
-38.2773%
-17.1812%
6.1952%
41.5323%
39.9779%
10.2473%
-9.9223%
-1,130.5686%
-179.6526%
-122.7009%
-90.0373%
138.4667%
490.5514%
-3.8211%
-34.4592%
-203.6457%
-48.876%
-26.035%
-1.1425%
31.2577%
53.0616%
44.5745%
30.8073%
157.3944%
-25.9185%
-69.3824%
-28.4806%
1.8914%
4.2594%
33.2855%
13.5444%
-4.0341%
13.7622%
-4.9342%
3.0694%
13.5534%
-58.4332%
-121.0968%
-15.5015%
-21.5081%
44.1585%
487.9561%
30.7951%
25.8969%
-8.5475%
-11.4552%
-11.8533%
12.1359%
17.9705%
2.3047%
-2.2961%
-48.5803%
-53.225%
-36.9313%
-23.2267%
4.549%
-1.4244%
-18.6538%
-100.4273%
71.6827%
-471.7474%
-83.9814%
-2.836%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.